Professional Documents
Culture Documents
Electrolyte Management in a
Surgical Patient
Dr. Babangida Sabo Miya
Moderator: Prof. Dauda M. M
ABUTH, Zaria.
30/11/2022
OUTLINE
• Introduction
• Physiology
• Fluid Therapy
• Daily maintenance / requirement
• Dehydration
• Overhydration
• Electrolyte Disorders
• Peri-operative fluid Therapy
• Conclusion
INTRODUCTION
• Fluid & electrolyte management is paramount in the care of
surgical patients.
• Women=50%; neonates=80%
• Distribution of TBW
• intracellular=40%
• extracellular=20%
• plasma-5%
• interstitial=15%
Control of body fluids
• Thirst center in hypothalamus
• Anti-diuretic hormone (ADH) in posterior pituitary
Fluid sources
• exogenous
• endogenous
Fluid loses:
• insensible loss
• urine
• faeces
• The main cation and anion in the ECF & ICF are Na+ & Cl- ; K+ & Po4
• ECF and ICF contain different types of solute but conc. of solutes
inside and outside the cells are equal
• Plasma osmolality
• Two no of anions accompanying Na+ while 18 and 2.8 are correction factors in
converting Glucose and Urea conc. from mg/dl to mmol/L
FLUID THERAPY
• Maintenance i.e. daily requirement
• Deficits
• Ongoing loses
MAINTENANCE
Water Losses Tropics/ml Temperate
• Pulm. & Cutaneous 1,700 1,000
• Urine 1,500
1,500
200
• Faeces 200 2,700
• Total 3,400
Water gain
Endogenous gain 200 200
• In Adult
- Avg water req. -- 30-40ml/kg
• In Children
-100ml/kg for first 10kg
-50ml/kg for next 10kg
-20ml/kg for each kg over 20kg
Na+ maintenance: Tropics Temperate
• Urine Loss 114mmol 80-110mmol
• Sweat 10-16mmol
• For Anions:
• (Expected –Observed) x Body weight(Kg) x 0.3
• Requirement/correction:
• Deficit + Maintenance
• severe dehydration
• Sunken eye
• Hypotension/shock, oliguria/anuria, cold-clammy
extremities
Treatment
• Replace loss/deficit
• Monitoring
• level of consciousness,
• state of hydration of the tongue or skin,
• hourly urine output,
• vital signs including capillary refill
• auscultation of lungs,
• JVP
• CVP monitoring
• Serial U & E
OVERHYDRATION
• Commonly found in fluid administration
• without monitoring
• more than what kidneys can excrete
• renal/hepatic disease
• Congestive heart failure
• Discontinue infusion
• Morphine
Hypokalaemia
• Most body K is in the ICF
• Grading
• Mild: 3 – 3.5
• Moderate: 2.5 – 3
• Severe: < 2.5
• Causes
• Inadequate potassium intake
• Excessive renal potassium excretion
• GIT - diarrhea, fistulas, vomiting, or high nasogastric output, typhoid
perforation
• Intracellular shifts from metabolic alkalosis or insulin therapy
• Drugs - amphotericin, aminoglycosides, foscarnet, cisplatin,
• Features:
• Moderate to severe:
• Darrows soln
• Potassium chloride infusion
CAUTION DURING THERAPY
• Never inject it as a bolus
• Adequate urine output
• Under ECG monitoring
CAUSES
• Increased intake
• Potassium supplementation
• Multiple Blood transfusions
• Endogenous load/destruction: hemolysis, crush injury
• Increased release
• Acidosis
• Rapid rise of extracellular osmolality
• Impaired excretion
• Potassium-sparing diuretics
• Renal insufficiency/failure
CLINICAL FEATURE
• GI :- Nausea/vomiting, colic, diarrhea
• Neuromuscular :- Weakness, paralysis, respiratory
failure
• Cardiovascular :- Arrhythmia, arrest
• ECG Finding
• high peaked T waves (early)
• widened QRS complex
• flattened P wave
• prolonged PR interval (first-degree block)
• sine wave formation, and ventricular fibrillation
Treatment
• Stop all K-containing fluid medications
• Counteract cardiac effects
• Calcium: iv 10mls of 10% calcium gluconate or calcium
chloride over 3-5minutes
• Potassium removal
• Ion-exchange resins e.g. Calcium resonium or kayexalate
• Oral administration is 15–30 g in 50–100 ml of 20% sorbitol
• Rectal administration is 50 g in 200 ml of 20% sorbitol
• Shift potassium
• 50% dextrose and regular insulin 5–10 units iv
• Bicarbonate : iv 8.4% nahco3 1-2mmols/kg over 10-15 mins
• Dialysis
CALCIUM
• majority is within the bone matrix
• <1% found in the ECF.
CAUSE
• Primary hyperparathyroidism
• malignancy
• bony metastasis
• secretion of parathyroid hormone
SYMPTOMS
• neurologic impairment, musculoskeletal weakness and
pain
• renal dysfunction
• In malignancy
HYPOCALCEMIA
• serum calcium level below 8.5 mEq/L or
• ionized calcium level below 4.2 mg/dL.
CAUSES
• Pancreatitis, renal failure, pancreatic and small bowel fistulas,
hypoparathyroidism, toxic shock syndrome, Massive blood transfusion
and tumor lysis syndrome
CLINICAL FINDINGS
• paresthesias of the face and extremities,
• muscle cramps, carpopedal spasm, stridor, tetany, and seizures
• hyperreflexia
• positive Chvostek's sign
• Trousseau's sign
• ECG changes prolonged QT interval, T-wave inversion, heart block, and
ventricular fibrillation.
TREATMENT
• Asymptomatic
• oral or IV calcium
• Acute symptomatic
• IV 10% calcium gluconate .
• 10ml of 10% Calcium gluconate over 5-10mins
• corrected Ca2+
• measured serum Ca2+ + 0.8 (4- measured serum Alb)
• Hypermagnesaemia is rare
CAUSE
• severe renal insufficiency
• Excess intake - TPN, Magnesium-containing antacids and
laxatives
• massive trauma, thermal injury, and severe acidosis
CLINICAL EXAMINATION
• nausea and vomiting
• neuromuscular dysfunction - weakness, lethargy,
hyporeflexia
• impaired cardiac conduction
• ECG changes :-Prolonged PR interval, widened QRS
complex, and elevated T waves.
TREATMENT
• Eliminate exogenous sources
• Correct acidosis
• Haemodialysis
HYPOMAGNESEMIA
• a common problem
• Causes
• Poor intake - starvation, alcoholism, prolonged IV fluid therapy
• Renal losses - alcohol abuse, diuretic use, amphotericin B, and
primary aldosteronism
• GI losses - diarrhea, malabsorption, and acute pancreatitis.
• Blood loss
• Guidelines
• Blood should be replaced as lost
• Fluid replacement should begin during
the operative procedure
POSTOPERATIVE THERAPY
• Immediate postoperative period
-Correct existing deficit in addition to daily
maintenance
-Hourly urinary monitor
-Strict Input/Output chart
CONCLUSION
• Fluid therapy must include replacement of deficits, administration of
daily requirements & replacement of ongoing loss.